Norfolk, Va.-based Children's Hospital of the King's Daughter is laying off 203 employees. The layoffs will be effective by Feb. 2, according to regulatory documents filed with the state on Nov. 15.

David Peter, MD, has been appointed as chief medical officer of The Clinic by Cleveland Clinic — a segment of the health system focused on virtual second opinions.

Health systems are turning to advanced practice provider care to increase capacity and patient access. Projections from the Bureau of Labor Statistics said that nurse practitioners are the ...

Westchester Medical Center Health Network announces changes to operating model, including elimination of regional CEO positions and retirement of current CEO.

Joe Flanagan has returned as CEO of R1 RCM following the completion of TowerBrook Capital Partners and Clayton, Dubilier & Rice's $8.9 billion deal to take the company private. Here are six things to ...

Orlando (Fla.) Health has appointed Howard Brown CFO for Orlando Health Dr. P. Phillips Hospital, a 285-bed acute care facility. Mr. Brown has two decades of financial healthcare experience and for ...

"Our 170-year legacy is a testament to the strength and vision of our organization, and Erik is the right leader to build on this foundation," Dr. Hochman remarked during a fireside chat at the Becker ...

An old challenge is quickly becoming the hospital C-suite buzzword for 2025. It's "access to care." Last year we heard all about incorporating artificial intelligence smartly into healthcare. This ...

President-elect Donald Trump has appointed Mehmet Oz, MD, as Administrator for the Centers for Medicare and Medicaid Services.

Mid-Valley Hospital and Clinic in Omak, Wash., has agreed to pay a $15,000 penalty for violations of the Controlled Substances Act and to implement changes to its pharmacy and controlled substances ...

Hospitals and health systems should be bracing for an 8% and 25% increase in demand for inpatient and outpatient cardiac procedures, respectively, over the next 10 years, according to a new report ...

Study estimates 136.8 million U.S. adults are eligible for semaglutide, a popular therapy for diabetes, weight loss, and cardiovascular disease.